Weightwatchers recordsdata for chapter as Ozempic and Mounjaro surge in recognition | EUROtoday

WeightWatchers has filed for chapter within the US because it struggles with debt and fierce competitors from fat-loss jabs like Ozempic and Mounjaro.

The authorized course of will see $1.15bn (£860mn) of the 60-year-old eating regimen model’s debt written off whereas it agrees new phrases for paying again its lenders.

WeightWatchers mentioned it’s going to stay “fully operational” throughout the course of with “no impact to members”.

It follows the meteoric rise in recognition of weightloss injections in what the agency mentioned was a “rapidly changing weight management landscape”.

“WeightWatchers has empowered millions of members to make informed, healthy choices, staying resilient as trends have come and gone,” mentioned chief government Tara Comonte.